Greenwich LifeSciences, Inc.
GLSIHealthcare|Biotechnology|US
$15.17
+0.52 (+3.55%)
DCF Value
$0.13
Tangible Book / Share
$0.21
Cash / Share
$0.61
Ownership Breakdown
52.1%
Float
14.7M
Shares Outstanding
7.6M
Float Shares
Insider Trades (100)
Last 4 quarters: 158,900 acquired · 0 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Jul 29, 2026 | BUY | 700 | $13.10 | $9.2K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Jul 28, 2026 | BUY | 1,500 | $13.59 | $20.4K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Jul 27, 2026 | BUY | 1,500 | $13.62 | $20.4K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Jul 24, 2026 | BUY | 1,100 | $12.88 | $14.2K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Jul 23, 2026 | BUY | 2,500 | $13.14 | $32.9K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Jan 13, 2026 | BUY | 1,800 | $29.83 | $53.7K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Jan 12, 2026 | BUY | 2,900 | $27.54 | $79.9K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Dec 31, 2025 | BUY | 4,300 | $21.36 | $91.8K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Dec 30, 2025 | BUY | 2,900 | $21.73 | $63.0K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Dec 18, 2025 | BUY | 4,100 | $12.62 | $51.7K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Nov 25, 2025 | BUY | 4,600 | $8.37 | $38.5K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Nov 13, 2025 | AWARD | 100,000 | $8.20 | $820.0K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Nov 7, 2025 | BUY | 10,600 | $8.43 | $89.4K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Oct 31, 2025 | BUY | 2,300 | $9.26 | $21.3K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Apr 25, 2025 | BUY | 3,600 | $9.88 | $35.6K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Apr 17, 2025 | BUY | 5,400 | $8.98 | $48.5K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Apr 7, 2025 | BUY | 3,600 | $9.10 | $32.8K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Apr 4, 2025 | BUY | 5,500 | $8.73 | $48.0K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Jan 10, 2025 | BUY | 2,500 | $12.51 | $31.3K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Jan 7, 2025 | BUY | 1,800 | $13.75 | $24.8K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Jan 6, 2025 | BUY | 1,100 | $13.31 | $14.6K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Jan 3, 2025 | BUY | 3,400 | $12.95 | $44.0K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Jan 2, 2025 | BUY | 2,000 | $11.97 | $23.9K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Dec 31, 2024 | BUY | 2,400 | $11.36 | $27.3K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Dec 30, 2024 | BUY | 3,200 | $11.12 | $35.6K | Form 4 |
| Daugherty Frank Joseph | director, officer: Chief Medical Officer | Dec 24, 2024 | AWARD | 104,890 | $12.16 | $1.3M | Form 4 |
| Hallock Kenneth | director | Dec 24, 2024 | AWARD | 41,349 | $12.16 | $502.8K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Dec 24, 2024 | AWARD | 25,008 | $12.16 | $304.1K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Dec 24, 2024 | AWARD | 1,148,723 | $12.16 | $14.0M | Form 4 |
| Rothe Eric | director | Dec 24, 2024 | AWARD | 41,349 | $12.16 | $502.8K | Form 4 |
| Thompson Jaye | VP Clinical Reg Affairs | Dec 24, 2024 | AWARD | 149,818 | $12.16 | $1.8M | Form 4 |
| McWilliams David | director | Dec 24, 2024 | AWARD | 61,984 | $12.16 | $753.7K | Form 4 |
| Thompson Jaye | VP Clinical Reg Affairs | Nov 21, 2024 | BUY | 1,000 | $12.91 | $12.9K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Sep 26, 2024 | BUY | 1,500 | $14.63 | $21.9K | Form 4 |
| Thompson Jaye | VP Clinical Reg Affairs | Aug 12, 2024 | BUY | 800 | $13.85 | $11.1K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Aug 6, 2024 | BUY | 2,000 | $13.81 | $27.6K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Aug 5, 2024 | BUY | 5,500 | $13.18 | $72.5K | Form 4 |
| Thompson Jaye | VP Clinical Reg Affairs | Aug 2, 2024 | BUY | 1,000 | $15.15 | $15.2K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Jul 23, 2024 | BUY | 1,500 | $15.89 | $23.8K | Form 4 |
| Thompson Jaye | VP Clinical Reg Affairs | Jul 18, 2024 | BUY | 1,000 | $16.00 | $16.0K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Jun 13, 2024 | BUY | 174,825 | $14.30 | $2.5M | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Apr 1, 2024 | BUY | 3,000 | $19.08 | $57.2K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Mar 22, 2024 | BUY | 2,500 | $19.98 | $50.0K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Mar 20, 2024 | BUY | 1,500 | $17.68 | $26.5K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Mar 5, 2024 | BUY | 30,500 | $12.49 | $380.9K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Mar 4, 2024 | BUY | 4,100 | $13.03 | $53.4K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Feb 16, 2024 | BUY | 10,800 | $11.16 | $120.5K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Feb 15, 2024 | BUY | 12,700 | $11.07 | $140.6K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Nov 10, 2023 | BUY | 5,000 | $10.17 | $50.8K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Nov 3, 2023 | BUY | 3,500 | $9.11 | $31.9K | Form 4 |
| Thompson Jaye | VP Clinical Reg Affairs | Oct 27, 2023 | BUY | 500 | $8.57 | $4.3K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Oct 26, 2023 | BUY | 2,500 | $7.97 | $19.9K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Oct 25, 2023 | BUY | 2,500 | $7.91 | $19.8K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Oct 10, 2023 | BUY | 1,000 | $9.07 | $9.1K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Oct 4, 2023 | BUY | 2,000 | $8.63 | $17.3K | Form 4 |
| Thompson Jaye | VP Clinical Reg Affairs | Sep 26, 2023 | BUY | 600 | $8.71 | $5.2K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Sep 19, 2023 | BUY | 4,000 | $8.95 | $35.8K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Sep 11, 2023 | BUY | 1,000 | $9.48 | $9.5K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Aug 22, 2023 | BUY | 1,000 | $9.97 | $10.0K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Aug 4, 2023 | BUY | 2,000 | $10.55 | $21.1K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Jul 21, 2023 | BUY | 1,000 | $9.20 | $9.2K | Form 4 |
| Thompson Jaye | VP Clinical Reg Affairs | Jul 13, 2023 | BUY | 250 | $9.49 | $2.4K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | May 17, 2023 | BUY | 1,000 | $11.69 | $11.7K | Form 4 |
| Thompson Jaye | VP Clinical Reg Affairs | Apr 28, 2023 | BUY | 250 | $11.22 | $2.8K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Apr 19, 2023 | BUY | 7,000 | $11.10 | $77.7K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Apr 18, 2023 | BUY | 2,000 | $11.12 | $22.2K | Form 4 |
| Thompson Jaye | VP Clinical Reg Affairs | Apr 11, 2023 | BUY | 1,000 | $11.87 | $11.9K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Apr 11, 2023 | BUY | 5,000 | $12.42 | $62.1K | Form 4 |
| Thompson Jaye | VP Clinical Reg Affairs | Mar 15, 2023 | BUY | 250 | $12.71 | $3.2K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Mar 10, 2023 | BUY | 1,000 | $12.12 | $12.1K | Form 4 |
| Thompson Jaye | VP Clinical Reg Affairs | Feb 24, 2023 | BUY | 250 | $15.39 | $3.8K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Feb 17, 2023 | BUY | 600 | $16.53 | $9.9K | Form 4 |
| Patel Snehal | director, 10 percent owner, officer: CEO and CFO | Feb 10, 2023 | BUY | 1,000 | $18.68 | $18.7K | Form 4 |
| Thompson Jaye | VP Clinical Reg Affairs | Feb 3, 2023 | BUY | 250 | $20.84 | $5.2K | Form 4 |
| Patel Snehal | CEO and CFO | Jan 27, 2023 | BUY | 2,000 | $19.35 | $38.7K | Form 4 |
| Thompson Jaye | VP Clinical Reg Affairs | Jan 27, 2023 | BUY | 250 | $19.20 | $4.8K | Form 4 |
| Patel Snehal | CEO and CFO | Jan 20, 2023 | BUY | 1,500 | $17.37 | $26.1K | Form 4 |
| Thompson Jaye | VP Clinical Reg Affairs | Jan 13, 2023 | BUY | 250 | $16.50 | $4.1K | Form 4 |
| Patel Snehal | CEO and CFO | Jan 6, 2023 | BUY | 1,500 | $15.18 | $22.8K | Form 4 |
| Patel Snehal | CEO and CFO | Dec 29, 2022 | BUY | 4,000 | $15.19 | $60.8K | Form 4 |
| Patel Snehal | CEO and CFO | Dec 16, 2022 | BUY | 1,000 | $13.01 | $13.0K | Form 4 |
| Thompson Jaye | VP Clinical Reg Affairs | Dec 16, 2022 | BUY | 250 | $12.94 | $3.2K | Form 4 |
| Patel Snehal | CEO and CFO | Dec 9, 2022 | BUY | 2,000 | $13.11 | $26.2K | Form 4 |
| Patel Snehal | CEO and CFO | Dec 2, 2022 | BUY | 1,000 | $13.84 | $13.8K | Form 4 |
| Thompson Jaye | VP Clinical Reg Affairs | Dec 2, 2022 | BUY | 250 | $13.98 | $3.5K | Form 4 |
| Patel Snehal | CEO and CFO | Nov 2, 2022 | BUY | 2,000 | $8.79 | $17.6K | Form 4 |
| Patel Snehal | CEO and CFO | Oct 14, 2022 | BUY | 3,000 | $9.75 | $29.3K | Form 4 |
| Patel Snehal | CEO and CFO | Oct 7, 2022 | BUY | 2,000 | $9.72 | $19.4K | Form 4 |
| Patel Snehal | CEO and CFO | Sep 30, 2022 | BUY | 1,000 | $9.46 | $9.5K | Form 4 |
| Patel Snehal | CEO and CFO | Sep 29, 2022 | BUY | 1,000 | $9.23 | $9.2K | Form 4 |
| Patel Snehal | CEO and CFO | Jun 24, 2022 | BUY | 22,535 | $9.13 | $205.7K | Form 4 |
| Daugherty Frank Joseph | director, officer: Chief Medical Officer | Jun 22, 2022 | AWARD | 104,890 | $7.63 | $800.3K | Form 4 |
| Daugherty Frank Joseph | Chief Medical Officer | Jun 22, 2022 | AWARD | 104,890 | — | — | Form 4 |
| Patel Snehal | CEO and CFO | Jun 22, 2022 | AWARD | 25,008 | — | — | Form 4 |
| Thompson Jaye | VP Clinical Reg Affairs | Jun 22, 2022 | AWARD | 149,818 | — | — | Form 4 |
| Hallock Kenneth | director | Jun 22, 2022 | AWARD | 41,349 | $7.63 | $315.5K | Form 4 |
| Hallock Kenneth | director: | Jun 22, 2022 | AWARD | 41,349 | — | — | Form 4 |
| Rothe Eric | director: | Jun 22, 2022 | AWARD | 41,349 | — | — | Form 4 |
| McWilliams David | director: | Jun 22, 2022 | AWARD | 61,984 | — | — | Form 4 |
| Patel Snehal | CEO and CFO | Jun 16, 2022 | BUY | 8,000 | $7.13 | $57.0K | Form 4 |